Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI.
Fioretti F, Butler J, Udell JA, Schuyler Jones W, Petrie MC, Harrington J, Mattheus M, Bauersachs J, Bayes-Genis A, Goodman SG, Gasior T, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Anker SD.
Fioretti F, et al. Among authors: udell ja.
ESC Heart Fail. 2025 Dec;12(6):3940-3952. doi: 10.1002/ehf2.15393. Epub 2025 Sep 14.
ESC Heart Fail. 2025.
PMID: 40947857
Free PMC article.
Clinical Trial.